abstract |
The present invention relates to FGFR4 kinase inhibitors and methods for their preparation and uses. The present invention relates to a compound of formula I or a pharmaceutically acceptable salt, solvate, polymorph or isomer thereof and their use in the manufacture of a medicament for the treatment of a FGFR4-mediated disease. |